199 related articles for article (PubMed ID: 15488605)
1. Complement-opsonized HIV: the free rider on its way to infection.
Stoiber H; Pruenster M; Ammann CG; Dierich MP
Mol Immunol; 2005 Feb; 42(2):153-60. PubMed ID: 15488605
[TBL] [Abstract][Full Text] [Related]
2. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.
Sullivan BL; Knopoff EJ; Saifuddin M; Takefman DM; Saarloos MN; Sha BE; Spear GT
J Immunol; 1996 Aug; 157(4):1791-8. PubMed ID: 8759769
[TBL] [Abstract][Full Text] [Related]
4. HIV and human complement: inefficient virolysis and effective adherence.
Bánki Z; Stoiber H; Dierich MP
Immunol Lett; 2005 Mar; 97(2):209-14. PubMed ID: 15752560
[TBL] [Abstract][Full Text] [Related]
5. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis.
Cole DS; Hughes TR; Gasque P; Morgan BP
Mol Immunol; 2006 May; 43(12):1953-64. PubMed ID: 16406094
[TBL] [Abstract][Full Text] [Related]
6. Primary human hepatocytes are protected against complement by multiple regulators.
Halme J; Sachse M; Vogel H; Giese T; Klar E; Kirschfink M
Mol Immunol; 2009 Jul; 46(11-12):2284-9. PubMed ID: 19446335
[TBL] [Abstract][Full Text] [Related]
7. Complement-HIV interactions during all steps of viral pathogenesis.
Stoiber H; Banki Z; Wilflingseder D; Dierich MP
Vaccine; 2008 Jun; 26(24):3046-54. PubMed ID: 18191309
[TBL] [Abstract][Full Text] [Related]
8. T-cell regulation: with complements from innate immunity.
Kemper C; Atkinson JP
Nat Rev Immunol; 2007 Jan; 7(1):9-18. PubMed ID: 17170757
[TBL] [Abstract][Full Text] [Related]
9. Complement, Fc receptors and antibodies: a Trojan horse in HIV infection?
Stoiber H
Curr Opin HIV AIDS; 2009 Sep; 4(5):394-9. PubMed ID: 20048703
[TBL] [Abstract][Full Text] [Related]
10. Loss of self-control in the complement system and innate autoreactivity.
Meri S
Ann N Y Acad Sci; 2007 Aug; 1109():93-105. PubMed ID: 17785294
[TBL] [Abstract][Full Text] [Related]
11. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
12. Presence of autoantibodies against complement regulatory proteins in relapsing-remitting multiple sclerosis.
Pintér C; Beltrami S; Caputo D; Ferrante P; Clivio A
J Neurovirol; 2000 May; 6 Suppl 2():S42-6. PubMed ID: 10871784
[TBL] [Abstract][Full Text] [Related]
13. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
14. Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
[TBL] [Abstract][Full Text] [Related]
15. HIV and complement: hijacking an immune defense.
Datta PK; Rappaport J
Biomed Pharmacother; 2006 Nov; 60(9):561-8. PubMed ID: 16978830
[TBL] [Abstract][Full Text] [Related]
16. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Okroj M; Corrales L; Stokowska A; Pio R; Blom AM
Cancer Immunol Immunother; 2009 Nov; 58(11):1771-80. PubMed ID: 19259664
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
[TBL] [Abstract][Full Text] [Related]
19. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
Livingston PO; Hood C; Krug LM; Warren N; Kris MG; Brezicka T; Ragupathi G
Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory evaluation of complement deficiency.
Wen L; Atkinson JP; Giclas PC
J Allergy Clin Immunol; 2004 Apr; 113(4):585-93; quiz 594. PubMed ID: 15100659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
